论文部分内容阅读
目的:分析雾化吸入普米克·令舒治疗慢性阻塞性肺疾病急性加重期的护理效果。方法:将2012年11月至2014年11月收治的慢性阻塞性肺疾病急性加重期98例患者均分为观察组49例以及对照组49例。其中观察组给予普米克令舒治疗;对照组给予常规抗炎治疗,对比分析两组患者的治疗效果。结果:在经过不同治疗方案后,无论是在临床症状评分、呼吸困难评分、PaO2以及PaCO2等各项指标中,观察组明显优于对照组,(P<0.05)具有显著差异。结论:在对慢性阻塞性肺疾病急性加重期患者进行治疗的过程中,采用普米克令舒治疗能够对患者的临床症状起到很好的改善作用,同时不良反应少,在临床中值得推广使用。
OBJECTIVE: To analyze the nursing effects of inhalation of Pulmicort Respirator on acute exacerbation of chronic obstructive pulmonary disease. Methods: A total of 98 patients with chronic obstructive pulmonary disease (COPD) exacerbated from November 2012 to November 2014 were divided into observation group (49 cases) and control group (49 cases). Among them, the observation group received Pulmicort resp. The control group was given conventional anti-inflammatory treatment, and the treatment effect was compared between the two groups. Results: After different treatment regimens, the observation group was significantly better than the control group (P <0.05) in the clinical symptom score, dyspnea score, PaO2 and PaCO2 and other indicators. Conclusion: In the treatment of patients with acute exacerbation of chronic obstructive pulmonary disease, the treatment with pulmicort may play a good role in improving the clinical symptoms of patients, with fewer adverse reactions, which is worthy of promotion in clinical practice .